Overview

A Drug-Drug Interaction Study of N91115 +/- Rifampin in Healthy Adult Subjects

Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
The present study is designed to assess the effects of Rifampin on the pharmacokinetics of N91115 in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Nivalis Therapeutics, Inc.
Collaborator:
Davita Clinical Research
Treatments:
Rifampin